Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0U4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of SKYRIZI 360 MG/2.4 ML on-body 2.4ML, a pharmaceutical product used in dermatological treatment. The contract is unset-aside and competitively awarded, with performance to be completed by February 11, 2026, at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier to federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the contractor to supply a vast range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen delivers specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FN0U4?
SPE2DR26FN0U4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FN0U4 worth?
The government has obligated $12,467 on SPE2DR26FN0U4.
Is contract SPE2DR26FN0U4 an order under another contract?
Yes. SPE2DR26FN0U4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0U4 competed?
The extent of competition for SPE2DR26FN0U4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award